Pain Management for Older Infants During Immunisation: A pilot randomised, controlled trial(The MINDI Trial Pilot Study)
- Conditions
- Acute painPain managementPublic Health - Other public health
- Registration Number
- ACTRN12614000784617
- Lead Sponsor
- niversity of Western Sydney
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Healthy infants attending the immunisation clinics for the scheduled 12-month immunisations will be recruited.
The following infants will be excluded from participating in the study:
Breastfeeding infants whose parents choose to breastfeed during immunisation;
Infants who have received an analgesic in the previous 24 hours including paracetamol, so as to not affect the response to painful stimuli during the procedure;
Infants who cannot receive their immunisation due to the presence of immunisation risk factors as cited in the Australian Immunisation Handbook (and as determined by the Immunisation Nurses);
Infants who are not able to be administered a sugar solution (as reported by the parents), and
Non-English speaking parents/guardians that do not have access to English translation at the time of the enrolment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Infant pain:<br>Pain will be measured using the validated Modified Behavioural Pain Scale (MBPS).[Baseline, during the first, and during the second injection, and 2 minutes post second (final) injection]
- Secondary Outcome Measures
Name Time Method Total duration of crying time:<br>Crying will be defined as the presence of audible negative vocalisations in combination with facial grimacing. <br>[Crying time will be measured from the insertion of the first needle to cessation of crying or up to 3 minutes after the second (last injection), and whichever occurs first.<br>];Incidence of crying (yes/no)[During immunisation ];Parental/guardian perception of infant pain using the Visual Analogue Scale (VAS).[Within 3 minutes after the 2nd (final) injection.]